TY - JOUR
TI - Efficacy and safety of weekly carfilzomib (70 mg/m2), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more convenient dosing option: a cross-study comparison of the CANDOR and EQUULEUS studies
AU - Leleu, Xavier
AU - Beksac, Meral
AU - Chou, Takaaki
AU - Dimopoulos, Meletios
AU - Yoon, Sung-Soo
AU - Prince, H Miles
AU - Pour, Ludek
AU - Shelekhova, Tatiana
AU - Chari, Ajai
AU - Khurana, Monica
AU - others
JO - Leukemia & Lymphoma
PY - 1998
VL - 62
TODO - 2
SP - 358--367
PB - Taylor & Francis
SN - 1042-8194, 1029-2403
TODO - null
TODO - null
TODO - null
ER -